GDR — Genedrive Income Statement
0.000.00%
Last trade - 00:00- £10.55m
- £8.46m
- £0.50m
Annual income statement for Genedrive, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.06 | 0.687 | 0.049 | 0.055 | 0.501 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 6.7 | 6.17 | 5.66 | 5.28 | 5.81 |
| Operating Profit | -5.64 | -5.48 | -5.62 | -5.22 | -5.31 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -20.4 | -1.85 | -5.63 | -5.98 | -7.75 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -19.4 | -0.691 | -4.67 | -5.15 | -7.08 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -19.4 | -0.691 | -4.67 | -5.15 | -7.08 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -19.4 | -0.691 | -4.67 | -5.15 | -7.08 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.433 | -0.009 | -0.044 | -0.044 | -0.047 |